USPTO serial 88713141
REVERSE TRANSLATIONAL MEDICINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 1, 2020
- Examiner
- DINALLO, KEVIN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with REVERSE TRANSLATIONAL MEDICINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janice Housey
4 Weems Lane #240Winchester, VA 22601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of nervous system diseases, infectious diseases, neoplasms, immune system diseases, endocrine and metabolic diseases, circulatory system diseases, eye diseases; Veterinary preparations for the treatment of nervous system diseases, infectious diseases, neoplasms, immune system diseases, endocrine diseases, metabolic diseases, circulatory system diseases, eye diseases; Pharmaceutical preparations for immunotherapeutic use, pharmaceutical agents for the elimination of tumors, pharmaceutical preparations for the treatment of neurodegenerative diseases, pharmaceutical preparations, namely, immunogens; Pharmaceutical preparations, namely, antibodies used for the testing of the disease; Vaccines; Diagnostic preparations for medical use in the form of epitopes for detecting protein abnormalities; Pharmaceutical preparations, namely, synthetic peptides used for the treatment of central nervous system diseases, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; Hygiene preparations for medical use, namely, disinfectants; Biocides; Diagnostic preparations for medical or veterinary use; Sanitary towels for hygiene purposes; Dietetic foods for medical use; Dietetic beverages for medical use; Biological preparations for medical use in the form of protein antibodies directed against specific protein epitopes for use in the treatment of central nervous system diseases, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunological diseases, inflammatory diseases, respiratory diseases, psychological diseases; Anti-bacterial preparations, namely, antibacterial substances for medical use, anti-bacterial pharmaceutical preparations, bio-pharmaceutical preparations for the treatment of cancer; Protein dietary supplements | ACTIVE | — |
| 042 | Monitoring, inspection and analysis of biologically active chemicals for quality control purposes; Research in the field of pharmaceutical products, cosmetics and foodstuffs for others; Advisory and information services in the field of monitoring and control for purposes of quality control and analysis of biologically active chemicals; Research in the field of medical treatment and medical methods; Research in the field of biotechnology and antibodies; Medical and scientific research in the field of clinical trial review and research with regard to medical treatment; Research in the field of sanitary care; Monitoring and inspection of biological synthesis and pharmaceutical production for quality control purposes and for purposes of scientific research and research in the field of biology; Software design; Computer programming; Maintenance of software; Design and development of computer hardware; Software development; Consultancy and providing of information with respect to quality control of pharmaceutical products; Scientific research in the field of cancerous diseases; Scientific research with respect to chemistry | ACTIVE | — |
| 044 | Medical services; Medical services in the field of immunity; Provision of medical information; Medical examinations, namely, physical examinations for medical purposes; Pharmaceutical consulting in the manufacture of medicines; Services provided by consultants in nutrition and dietetics; Consultancy and providing of information in the field of sanitary care, namely, providing of health information in connection with health; Veterinary services; Beauty salon services; Animal care services, namely, veterinary care services; Medical consulting services for hygiene in the field of care; Medical consultancy and providing of medical information with respect to preparation, administration and dosing of pharmaceutical preparations; Consulting services with respect to preparation and administration of pharmaceutical products; Providing medical information for medical staff and for patients in the form of compiled reports in the field of diagnostic, prophylactic and therapeutic properties of medicines; Drug testing, namely, systematic testing of medicinal products for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Neurimmune Holding AG
- Other trademarks owned by Neurimmune Holding AG
- Other trademarks owned by Neurimmune Holding AG
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named REVERSE TRANSLATIONAL MEDICINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 1, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 19, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 19, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 19, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 12, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 12, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 12, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 12, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 12, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 12, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 21, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 21, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 21, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 21, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 21, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 21, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 21, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 21, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 21, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 1, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 26, 2020 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Sep 14, 2020 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Aug 4, 2020 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Aug 4, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 9, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 20, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 6, 2020 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| May 1, 2020 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Apr 30, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 30, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 30, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 30, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 24, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 17, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 7, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 6, 2019 | NWAP | NEW APPLICATION ENTERED | — |